AstraZeneca jab's benefits outweigh risks: ministry
AstraZeneca jab’s benefits outweigh risks: ministry NO SUSPENSION: The risk of embolism as a side effect of the vaccine might be lower in Asia, where more people have adenovirus antibodies, a virus expert said Staff writer, with CNA The Ministry of Health and Welfare yesterday recommended that the rollout of AstraZeneca’s COVID-19 vaccine should continue, adding that people would be informed of all known risks. The European Medicines Agency in a statement Wednesday said that “unusual blood clots with low blood platelets should be listed as ver...